RedHill Biopharma (RDHL) Times Interest Earned (2012 - 2023)

RedHill Biopharma (RDHL) has 12 years of Times Interest Earned data on file, last reported at $27.91 in Q2 2023.

• On a quarterly basis, Times Interest Earned rose 1184.06% year-over-year to $27.91 in Q2 2023; TTM through Jun 2023 was -$1.2, a 94.48% increase from a year earlier, with the FY2025 full-year figure at -$5.45, down 27.37% from the prior year.
• Times Interest Earned for Q2 2023 stood at $27.91, up from -$69.07 in the prior quarter.
• Over the last five years, Times Interest Earned for RDHL reached as high as $62.91 in Q4 2019 and fell as low as -$69.07 in Q1 2023.
• Historically, Times Interest Earned has averaged -$1.38 across 5 years, with a median of $3.62 in 2020.
• Across the five-year window, Times Interest Earned surged 1380.98% in 2019 and plunged 1723.72% in 2023, its largest moves.
• Year by year, Times Interest Earned stood at $62.91 in 2019, then sank by 114.42% to -$9.07 in 2020, then jumped by 305.17% to $18.61 in 2021, then sank by 264.06% to -$30.53 in 2022, then soared by 191.42% to $27.91 in 2023.
• Per Business Quant data, the three most recent Times Interest Earned figures were $27.91 in Q2 2023, -$69.07 in Q1 2023, and -$30.53 in Q4 2022.